Immediate and mid-term result of restrictive mitral annuloplasty using a small semi-rigid ring

Masayoshi Umesue, Hironori Baba, Satoshi Kimura

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: Though annuloplasty using a properly sized ring has been advocated in degenerative mitral regurgitation, restrictive annuloplasty using a down-sized ring is widely used in ischemic mitral regurgitation. We investigated the outcome of restrictive annuloplasty using a small (24- or 26-mm) ring in mitral regurgitation irrespective of the etiology. Methods: Nineteen patients underwent a restrictive annuloplasty using a 24-mm (n = 8) or 26-mm (n = 11) semi-rigid ring. The etiology included degenerative in 13 patients, ischemic in 3, endocarditis in 2, and congenital in 1. Body surface area of the patients implanted with the 24-mm ring was 1.40 ± 0.16 and 1.60 ± 0.18 m2 for the 26-mm ring. Fifteen patients had 3+ or 4+ mitral regurgitation preoperatively. Results: Two patients were converted to valve replacement for residual mitral regurgitation during the operation. One operative mortality associated with infection was observed. Echocardiogram at 29.4 ± 14.2 months postoperatively demonstrated mitral valve area of 2.0 ± 0.6 cm2 for 24-mm ring and 2.2 ± 0.5 cm2 for 26-mm ring with indexed mitral valve area of 1.4 ± 0.4 cm2/m2 for both groups, and no mitral regurgitation more than 2+. Transmitral mean pressure gradient on rest was 4.7 ± 2.1 mmHg at last follow up. New York Heart Association class improved from 2.2 ± 0.7 to 1.2 ± 0.2 after the operation. No late death or reoperation was observed during the follow-up of 31.0 ± 15.0 months. Conclusions: Restrictive mitral annuloplasty using a small ring provided acceptable early and midterm results in patients with body surface area around 1.5 cm2 without Barlow pathology. Restrictive annuloplasty may be another technical aspect to avoid valve replacement.

Original languageEnglish
Pages (from-to)260-266
Number of pages7
JournalGeneral thoracic and cardiovascular surgery
Volume64
Issue number5
DOIs
Publication statusPublished - May 1 2016

Fingerprint

Mitral Valve Annuloplasty
Mitral Valve Insufficiency
Body Surface Area
Mitral Valve
Endocarditis
Reoperation
Pathology
Pressure
Mortality
Infection

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Immediate and mid-term result of restrictive mitral annuloplasty using a small semi-rigid ring. / Umesue, Masayoshi; Baba, Hironori; Kimura, Satoshi.

In: General thoracic and cardiovascular surgery, Vol. 64, No. 5, 01.05.2016, p. 260-266.

Research output: Contribution to journalArticle

@article{4024a1adac7a44139f7166e1d36d22dd,
title = "Immediate and mid-term result of restrictive mitral annuloplasty using a small semi-rigid ring",
abstract = "Objective: Though annuloplasty using a properly sized ring has been advocated in degenerative mitral regurgitation, restrictive annuloplasty using a down-sized ring is widely used in ischemic mitral regurgitation. We investigated the outcome of restrictive annuloplasty using a small (24- or 26-mm) ring in mitral regurgitation irrespective of the etiology. Methods: Nineteen patients underwent a restrictive annuloplasty using a 24-mm (n = 8) or 26-mm (n = 11) semi-rigid ring. The etiology included degenerative in 13 patients, ischemic in 3, endocarditis in 2, and congenital in 1. Body surface area of the patients implanted with the 24-mm ring was 1.40 ± 0.16 and 1.60 ± 0.18 m2 for the 26-mm ring. Fifteen patients had 3+ or 4+ mitral regurgitation preoperatively. Results: Two patients were converted to valve replacement for residual mitral regurgitation during the operation. One operative mortality associated with infection was observed. Echocardiogram at 29.4 ± 14.2 months postoperatively demonstrated mitral valve area of 2.0 ± 0.6 cm2 for 24-mm ring and 2.2 ± 0.5 cm2 for 26-mm ring with indexed mitral valve area of 1.4 ± 0.4 cm2/m2 for both groups, and no mitral regurgitation more than 2+. Transmitral mean pressure gradient on rest was 4.7 ± 2.1 mmHg at last follow up. New York Heart Association class improved from 2.2 ± 0.7 to 1.2 ± 0.2 after the operation. No late death or reoperation was observed during the follow-up of 31.0 ± 15.0 months. Conclusions: Restrictive mitral annuloplasty using a small ring provided acceptable early and midterm results in patients with body surface area around 1.5 cm2 without Barlow pathology. Restrictive annuloplasty may be another technical aspect to avoid valve replacement.",
author = "Masayoshi Umesue and Hironori Baba and Satoshi Kimura",
year = "2016",
month = "5",
day = "1",
doi = "10.1007/s11748-016-0631-6",
language = "English",
volume = "64",
pages = "260--266",
journal = "General Thoracic and Cardiovascular Surgery",
issn = "1863-6705",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - Immediate and mid-term result of restrictive mitral annuloplasty using a small semi-rigid ring

AU - Umesue, Masayoshi

AU - Baba, Hironori

AU - Kimura, Satoshi

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Objective: Though annuloplasty using a properly sized ring has been advocated in degenerative mitral regurgitation, restrictive annuloplasty using a down-sized ring is widely used in ischemic mitral regurgitation. We investigated the outcome of restrictive annuloplasty using a small (24- or 26-mm) ring in mitral regurgitation irrespective of the etiology. Methods: Nineteen patients underwent a restrictive annuloplasty using a 24-mm (n = 8) or 26-mm (n = 11) semi-rigid ring. The etiology included degenerative in 13 patients, ischemic in 3, endocarditis in 2, and congenital in 1. Body surface area of the patients implanted with the 24-mm ring was 1.40 ± 0.16 and 1.60 ± 0.18 m2 for the 26-mm ring. Fifteen patients had 3+ or 4+ mitral regurgitation preoperatively. Results: Two patients were converted to valve replacement for residual mitral regurgitation during the operation. One operative mortality associated with infection was observed. Echocardiogram at 29.4 ± 14.2 months postoperatively demonstrated mitral valve area of 2.0 ± 0.6 cm2 for 24-mm ring and 2.2 ± 0.5 cm2 for 26-mm ring with indexed mitral valve area of 1.4 ± 0.4 cm2/m2 for both groups, and no mitral regurgitation more than 2+. Transmitral mean pressure gradient on rest was 4.7 ± 2.1 mmHg at last follow up. New York Heart Association class improved from 2.2 ± 0.7 to 1.2 ± 0.2 after the operation. No late death or reoperation was observed during the follow-up of 31.0 ± 15.0 months. Conclusions: Restrictive mitral annuloplasty using a small ring provided acceptable early and midterm results in patients with body surface area around 1.5 cm2 without Barlow pathology. Restrictive annuloplasty may be another technical aspect to avoid valve replacement.

AB - Objective: Though annuloplasty using a properly sized ring has been advocated in degenerative mitral regurgitation, restrictive annuloplasty using a down-sized ring is widely used in ischemic mitral regurgitation. We investigated the outcome of restrictive annuloplasty using a small (24- or 26-mm) ring in mitral regurgitation irrespective of the etiology. Methods: Nineteen patients underwent a restrictive annuloplasty using a 24-mm (n = 8) or 26-mm (n = 11) semi-rigid ring. The etiology included degenerative in 13 patients, ischemic in 3, endocarditis in 2, and congenital in 1. Body surface area of the patients implanted with the 24-mm ring was 1.40 ± 0.16 and 1.60 ± 0.18 m2 for the 26-mm ring. Fifteen patients had 3+ or 4+ mitral regurgitation preoperatively. Results: Two patients were converted to valve replacement for residual mitral regurgitation during the operation. One operative mortality associated with infection was observed. Echocardiogram at 29.4 ± 14.2 months postoperatively demonstrated mitral valve area of 2.0 ± 0.6 cm2 for 24-mm ring and 2.2 ± 0.5 cm2 for 26-mm ring with indexed mitral valve area of 1.4 ± 0.4 cm2/m2 for both groups, and no mitral regurgitation more than 2+. Transmitral mean pressure gradient on rest was 4.7 ± 2.1 mmHg at last follow up. New York Heart Association class improved from 2.2 ± 0.7 to 1.2 ± 0.2 after the operation. No late death or reoperation was observed during the follow-up of 31.0 ± 15.0 months. Conclusions: Restrictive mitral annuloplasty using a small ring provided acceptable early and midterm results in patients with body surface area around 1.5 cm2 without Barlow pathology. Restrictive annuloplasty may be another technical aspect to avoid valve replacement.

UR - http://www.scopus.com/inward/record.url?scp=84958769253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958769253&partnerID=8YFLogxK

U2 - 10.1007/s11748-016-0631-6

DO - 10.1007/s11748-016-0631-6

M3 - Article

C2 - 26884082

AN - SCOPUS:84958769253

VL - 64

SP - 260

EP - 266

JO - General Thoracic and Cardiovascular Surgery

JF - General Thoracic and Cardiovascular Surgery

SN - 1863-6705

IS - 5

ER -